You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The firm's tool combines enzymatic and mechanical disruption to produce viable and accurate products for downstream single-cell applications.
A judge has dismissed a lawsuit brought by Human Longevity against the J. Craig Venter Institute.
Human Longevity had filed the suit in July, alleging the misappropriation of trade secrets by Craig Venter, who founded both the company and the institute.
Using biorepository strains, researchers from the J. Craig Venter Institute and elsewhere profiled Zika virus consensus sequences, variant patterns, and phylogenetics.
Human Longevity alleges that Craig Venter stole trade secrets in a lawsuit filed against the J. Craig Venter Institute.
HLI claims that upon his termination in May, Venter took a company-owned laptop and is using HLI trade secrets to build a competing business at JCVI.
Craig Venter is retiring from Human Longevity to return to the research institution that bears his name, the San Diego Union-Tribune reports.
In PLOS this week: PCR-based approach to diagnose eye infection in cats and dogs, genomic analysis of Chinook salmon, and more.
Researchers detected excess genetic risk and/or misclassification when profiling ClinVar variants in ACMG-59 and OrphaNet genes using genome and exome sequences.
In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.
The head of Operation Warp Speed tells Bloomberg he expects the paused AstraZeneca and Johnson & Johnson vaccine trials to resume soon.
A new UK government says socioeconomic factors, not genetics, account for disparities in deaths due to COVID-19 between ethnic groups, the Financial Times reports.
NPR reports on an Alzheimer's disease drug trial that is continuing despite the pandemic.
In Nature this week: CRISPR-Cas3 system for making large deletions efficiently, more.